{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:30:11Z","timestamp":1782052211701,"version":"3.54.5"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Ophthalmol"],"published-print":{"date-parts":[[1975,1,1]]},"DOI":"10.1001\/archopht.1975.01010020050009","type":"journal-article","created":{"date-parts":[[2011,11,29]],"date-time":"2011-11-29T04:43:07Z","timestamp":1322541787000},"page":"46","source":"Crossref","is-referenced-by-count":33,"title":["Teratogenicities of Ophthalmic Drugs"],"prefix":"10.1001","volume":"93","author":[{"given":"Motokazu","family":"Itoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["Archives of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/archopht.jamanetwork.com\/ama\/content_public\/journal\/ophth\/17836\/archopht_93_1_009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T22:48:26Z","timestamp":1680907706000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/archopht.1975.01010020050009"}},"subtitle":["I. Antiviral Ophthalmic Drugs"],"short-title":[],"issued":{"date-parts":[[1975,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1975,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archopht.1975.01010020050009","relation":{},"ISSN":["0003-9950"],"issn-type":[{"value":"0003-9950","type":"print"}],"subject":[],"published":{"date-parts":[[1975,1,1]]}}}